Concepts (51)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pathology | 1 | 2023 | 11 | 0.840 |
Why?
|
| Pathology, Clinical | 1 | 2023 | 21 | 0.830 |
Why?
|
| Communicable Diseases | 1 | 2023 | 85 | 0.790 |
Why?
|
| Reagins | 1 | 2020 | 1 | 0.690 |
Why?
|
| Treponema pallidum | 1 | 2020 | 5 | 0.690 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2020 | 5 | 0.690 |
Why?
|
| Syphilis | 1 | 2020 | 25 | 0.670 |
Why?
|
| Carcinoma | 2 | 2018 | 116 | 0.620 |
Why?
|
| Sarcoma, Synovial | 1 | 2016 | 6 | 0.520 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2016 | 31 | 0.500 |
Why?
|
| Neuroendocrine Tumors | 1 | 2016 | 21 | 0.500 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 584 | 0.340 |
Why?
|
| Corynebacterium | 1 | 2025 | 2 | 0.240 |
Why?
|
| Tetracyclines | 1 | 2025 | 6 | 0.240 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2023 | 11 | 0.210 |
Why?
|
| Africa | 1 | 2023 | 21 | 0.210 |
Why?
|
| Pathology, Surgical | 1 | 2022 | 12 | 0.200 |
Why?
|
| Automation, Laboratory | 1 | 2020 | 8 | 0.170 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 317 | 0.170 |
Why?
|
| Viruses | 1 | 2021 | 78 | 0.170 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 43 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 735 | 0.160 |
Why?
|
| Antibodies, Bacterial | 1 | 2020 | 187 | 0.160 |
Why?
|
| Curriculum | 1 | 2023 | 560 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 130 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 1091 | 0.140 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2016 | 102 | 0.130 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 61 | 0.130 |
Why?
|
| Algorithms | 1 | 2020 | 974 | 0.120 |
Why?
|
| Humans | 8 | 2025 | 59389 | 0.120 |
Why?
|
| Cytoplasm | 1 | 2016 | 270 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 931 | 0.100 |
Why?
|
| United States | 2 | 2023 | 7426 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 2016 | 608 | 0.100 |
Why?
|
| Chromatin | 1 | 2016 | 599 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2025 | 191 | 0.060 |
Why?
|
| Female | 2 | 2023 | 30726 | 0.060 |
Why?
|
| Metagenomics | 1 | 2023 | 22 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2022 | 61 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2023 | 394 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 263 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2023 | 6071 | 0.050 |
Why?
|
| Seasons | 1 | 2021 | 123 | 0.040 |
Why?
|
| Aged | 1 | 2016 | 13408 | 0.040 |
Why?
|
| Patient Safety | 1 | 2022 | 237 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 79 | 0.040 |
Why?
|
| Observer Variation | 1 | 2018 | 205 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 248 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 617 | 0.030 |
Why?
|
| Male | 1 | 2016 | 27749 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1559 | 0.030 |
Why?
|